Hillsdale Investment Management Inc. Grows Stock Position in Nature’s Sunshine Products, Inc. $NATR

Hillsdale Investment Management Inc. increased its stake in Nature’s Sunshine Products, Inc. (NASDAQ:NATR) by 44.4% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 316,867 shares of the company’s stock after acquiring an additional 97,397 shares during the period. Hillsdale Investment Management Inc.’s holdings in Nature’s Sunshine Products were worth $7,602,000 as of its most recent SEC filing.

Several other institutional investors also recently bought and sold shares of the stock. First Trust Advisors LP grew its position in Nature’s Sunshine Products by 1.7% during the 4th quarter. First Trust Advisors LP now owns 44,803 shares of the company’s stock worth $967,000 after acquiring an additional 736 shares during the last quarter. Ameriprise Financial Inc. boosted its stake in shares of Nature’s Sunshine Products by 1.4% during the second quarter. Ameriprise Financial Inc. now owns 54,008 shares of the company’s stock valued at $799,000 after purchasing an additional 753 shares during the period. R Squared Ltd grew its holdings in shares of Nature’s Sunshine Products by 7.7% in the first quarter. R Squared Ltd now owns 15,340 shares of the company’s stock worth $368,000 after purchasing an additional 1,092 shares during the last quarter. State of Alaska Department of Revenue bought a new position in shares of Nature’s Sunshine Products in the fourth quarter worth approximately $31,000. Finally, Charles Schwab Investment Management Inc. grew its holdings in shares of Nature’s Sunshine Products by 3.1% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 49,798 shares of the company’s stock worth $1,075,000 after purchasing an additional 1,513 shares during the last quarter. 79.40% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at Nature’s Sunshine Products

In related news, EVP Daniel C. Norman sold 9,713 shares of Nature’s Sunshine Products stock in a transaction on Monday, June 1st. The shares were sold at an average price of $20.64, for a total value of $200,476.32. Following the sale, the executive vice president owned 47,276 shares in the company, valued at $975,776.64. The trade was a 17.04% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, EVP Kevin R. Herbert sold 2,000 shares of the business’s stock in a transaction on Friday, June 12th. The shares were sold at an average price of $20.68, for a total transaction of $41,360.00. Following the transaction, the executive vice president directly owned 48,866 shares in the company, valued at approximately $1,010,548.88. The trade was a 3.93% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last ninety days, insiders have sold 35,696 shares of company stock worth $742,407. 3.10% of the stock is currently owned by insiders.

Nature’s Sunshine Products Stock Performance

NASDAQ NATR opened at $21.58 on Tuesday. The stock has a market cap of $379.38 million, a P/E ratio of 19.62 and a beta of 0.87. Nature’s Sunshine Products, Inc. has a fifty-two week low of $12.97 and a fifty-two week high of $28.14. The stock has a 50 day simple moving average of $21.48 and a two-hundred day simple moving average of $23.72.

Nature’s Sunshine Products (NASDAQ:NATR) last posted its earnings results on Thursday, May 7th. The company reported $0.30 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.20 by $0.10. The firm had revenue of $122.89 million for the quarter, compared to analysts’ expectations of $122.15 million. Nature’s Sunshine Products had a return on equity of 14.67% and a net margin of 4.06%.

Analyst Upgrades and Downgrades

NATR has been the subject of a number of recent analyst reports. Weiss Ratings lowered shares of Nature’s Sunshine Products from a “buy (b-)” rating to a “hold (c+)” rating in a report on Tuesday, June 9th. DA Davidson raised shares of Nature’s Sunshine Products to a “strong-buy” rating in a report on Monday, July 6th. Finally, Canaccord Genuity Group set a $37.00 price objective on shares of Nature’s Sunshine Products in a research report on Friday, May 8th. One analyst has rated the stock with a Strong Buy rating, one has given a Buy rating and one has given a Hold rating to the stock. According to data from MarketBeat, Nature’s Sunshine Products presently has a consensus rating of “Buy” and a consensus price target of $35.00.

Nature’s Sunshine Products Company Profile

Nature’s Sunshine Products, Inc is a global manufacturer and direct seller of nutritional supplements, herbal remedies, and personal care products. The company’s core business centers on research, development and distribution of vitamins, minerals, botanicals and essential oil-based formulations designed to support overall health and wellness. Operating under a network-marketing model, Nature’s Sunshine works through a network of independent distributors who promote and sell its product line directly to consumers.

The company’s product portfolio spans dietary supplements such as single-ingredient vitamins, proprietary herbal blends, sports nutrition formulas and weight-management solutions, along with skin and hair care items based on botanical extracts and essential oils.